The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.13

Today's change-0.27 -1.87%
Updated December 11 12:10 PM EST. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $14.13

Today's change-0.27 -1.87%
Updated December 11 12:10 PM EST. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc down (U.S.)$0.27

Allscripts Healthcare Solutions Inc is sharply lower today, dropping (U.S.)$0.27 or 1.87% to (U.S.)$14.13. Shares have lost 0.42% over the last five days, but sit 2.59% below their 52-week high. This security has outperformed the S&P 500 by 9.61% during the last year.

Key company metrics

  • Open(U.S.) $14.19
  • Previous close(U.S.) $14.40
  • High(U.S.) $14.26
  • Low(U.S.) $13.72
  • Bid / Ask(U.S.) $14.12 / (U.S.) $14.13
  • YTD % change+38.39%
  • Volume1,738,384
  • Average volume (10-day)1,993,248
  • Average volume (1-month)2,073,954
  • Average volume (3-month)2,286,155
  • 52-week range(U.S.) $10.19 to (U.S.) $14.51
  • Beta1.34
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward23.27×
  • Forward PEG1.29×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.16
Updated December 11 12:10 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-9.69%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.09%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue449426413425
Total other revenue--------
Total revenue449426413425
Gross profit202187179186
Total cost of revenue248239235239
Total operating expense445550402413
Selling / general / administrative117112111115
Research & development51464948
Depreciation / amortization88711
Interest expense (income), net operating--------
Unusual expense (income)2114500
Other operating expenses, total--------
Operating income5-1231112
Interest income (expense), net non-operating-21-19-19-20
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-144-8-12
Income after tax-17-143-93
Income tax, total0-10-15
Net income-18-143-93
Total adjustments to net income-11-11-11-10
Net income before extra. items-18-143-93
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-29-154-20-7
Inc. avail. to common incl. extra. items-29-154-20-7
Diluted net income-29-154-20-7
Dilution adjustment--0----
Diluted weighted average shares181181181183
Diluted EPS excluding extraordinary itemsvalue per share-0.16-0.85-0.11-0.04
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.08-0.33-0.11-0.04